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SUMMARY
Cervical cancer constitutes a major health problem in developing countries like Bolivia. The roles of certain genotypes of human
papillomaviruses (HPVs) in the pathogenesis of cervical cancer is well established.  The prevalence of HPV infection among sexually
active women varies greatly.  Information regarding HPV infection in Bolivia is very much scarce, specially in regions like the
Amazonian lowland.
We studied 135 healthy women living in four rural localities of the Bolivian Amazon. Presence of HPV in DNA extracted from
cervical swabs was analyzed using a  reverse line hybridization assay. The estimated overall HPV infection prevalence among the
studied rural localities was 5.9% (ranging from 0-16.6%). These values were unexpectedly low considering Bolivia has a high
incidence of cervical cancer.
The fact that Amazonian people seem to be less exposed to HPV, makes it likely that  some other risk factors including host
lifestyle behaviors and genetic background may be involved in the development of cervical cancer in this population.
KEY WORDS: HPV; Cervical carcinoma; Rural Bolivia; Amazon.
INTRODUCTION
There is a central etiologic role of human papillomavirus (HPV)
infection in the development of cervical intraepithelial neoplasia (CIN)
and cervical carcinoma2,4,30. Cervical cancer constitutes a major health
problem world-wide, specially in Latin America. In Bolivia it particularly
affects women of reproductive age with low-income25. It has been
estimated that the incidence of cervical cancer in Bolivia lies among the
highest in the world. The incidence of cervical cancer in La Paz, the
largest city in Bolivia, has been reported to be 53.1/100,00024, and for
Oruro and Potosi (two other important cities in the Andean region) 60.9/
100,000 and 93.5/100,000 respectively23. Twenty-five percent of the total
number of women‘s deaths in Bolivia are due to cancer, of which 65%
correspond to cancer of the cervix22.
HPV belongs to the family Papovaviridae, non-enveloped closed,
circular, double-stranded DNA viruses with a genome size of about 8000
base-pairs.  So far, more than 100 different  HPV genotypes, defined on
the basis of DNA homology, have been identified, of which more than
40 infect the anogenital tract6. Infection with certain types of HPV is
considered a main risk factor for the development of cervical
cancer8,14,18,19,29. HPV infection precedes the development of cervical
cancer by several years2. Case-control studies, case series, and prevalence
surveys have shown that HPV DNA can be detected in adequate
specimens of cervical cancer in 90 to 100% of cases.
Since HPV persistence plays a central role in the etiology of cervical
cancer, the evaluation of HPV infection among general population is
important for surveillance of cervical cancer specially in rural populations
such as those in the Bolivian Amazon, where screening coverage is
reduced or sometimes inexistent. Although Bolivia bears a high incidence
of cervical cancer, little information regarding the prevalence of HPV
infection is available. This study aimed to investigate the extent of HPV
infection in rural villages of the Bolivian Amazonian lowland.
MATERIALS AND METHODS
Study region: The Bolivian country is divided into three regions, the
Andean Highland, the Central Valley and the Amazonian lowland.  This
latter region corresponds to 59% of the total territory.  We studied four
rural localities in the Amazonian lowland of Bolivia: San Ramón,
Caranavi, Palos Blancos, and Rurrenabaque (Fig. 1).
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been pregnant with 5 or more children.  The majority of the study
participants reported one lifetime sexual partner. More than 78% of the
women were non-smokers (with less than 10% of the women reporting
a history of smoking in some of the villages).
There was a significant statistical difference in the ethnic composition,
the distribution of marital status, smoking status, occupation, as well as
the number of pregnancies and abortions between the rural localities
studied. Other demographic variables like age, educational level, age of
first sexual intercourse, and number of sexual partners showed no
significant statistical difference.
The prevalence of HPV infection in each locality was: San Ramon
3.2% (2/63), Rurrenabaque 16.6% (2/12), Palos Blancos 0% (0/9) and
Caranavi 7.8% (4/51). The overall prevalence was 5.9% (8/135) (Table
2).
In the four rural localities studied, HPV typing revealed the presence
of four low risk HPV genotypes: HPV-6, HPV-11, HPV-66 and MM8
and five high risk genotypes: HPV-26, HPV-39, HPV-51, HPV-52, and
HPV-59 (Table 2). No specific HPV type was more frequent than the
others. Two cases of dual infection were found in Caranavi and
Rurrenabaque HPV-11 and HPV-39; and HPV-59 and MM8, respectively.
One case of multiple (triple) infection was found in San Ramon, where
HPV-66, HPV-26, and HPV-52 were found in the same sample.
DISCUSSION
Even though Bolivia is considered an Andean country, 59% of its
territory corresponds to the Amazonian region25. Is hard to obtain a value
of cervical cancer incidence for the whole country due to limitations in
the diagnosis and registration practices, specially in rural areas. Reports
from several Bolivian Andean cities, showed very high incidence rates
of cervical cancer23,24. Although these reports refer to Andean populations,
cervical cancer incidence might be also high in the Amazon taking into
account some studies done on indigenous women from Brazil3,27.
As infection with HPV is the main risk factor for the development
of cervical cancer2,30, in terms of HPV infection our study population
seems to be at low risk for developing cervical cancer. The estimated
overall HPV infection prevalence among the studied rural localities was
5.9%. It ranged from 0 to16.6% (no infection was found in the village of
Palos Blancos, probably due to the small sample size), these values were
lower than expected considering the high rates of cervical cancer
incidence reported for the country. A study done in rural Costa Rica
reported a prevalence of HPV infection of 11%11. The HPV infection
prevalence, however ranges from 10% to 50% in sexually active women,
being thus considered the most common sexually transmitted viral
disease10.
The low prevalence found, can still be due to a low sensitivity of the
method used, as some reports state that HPV infection can vary according
to the primers used in the detection28. However, we tested the samples
with a different HPV detection system, a PCR-RFLP method using
primers in the E6-E7 region7 and found a similar detection rate (data not
shown).
Four low risk (HPV-6, -11, -66 and MM8)20,21, and five high risk
Fig. 1 - Geographic location of the study area
Subjects and samples: We examined a total of 135 healthy women
living in four rural localities of the Bolivian Amazon (63 from San
Ramón, 51 from Caranavi, 9 from Palos Blancos and 12 from
Rurrenabaque). Women were invited to participate by local authorities
and medical personnel through local radio station.
After informed consent, pertinent demographic data was obtained
through a questionnaire, and participants received a routine gynecological
examination. Cervical swabs were collected from all women using a
cotton swab, and specimens were preserved in ethanol until their analysis.
Briefly, cervical epithelial exfoliated cells were suspended in 1 ml of
phosphate-buffered saline (PBS) in a 2 ml Eppendorf tube (Eppendorf,
Netheler-Hinz-GmbH, Germany), and then pelleted at 2000 rpm for 10
min.  The supernatant was discarded and 1 ml of 99% ethanol was added
to the cell pellet17.
HPV detection and genotyping: After DNA extraction by the
guanidine-HCl method (SMITEST EX&D, Sumitomo Metal Industry,
Japan),  samples were analyzed using a reverse line hybridization protocol
that allows discrimination of 27 HPV types9. Briefly, after a polymerase
chain reaction (PCR) amplification using HPV consensus primers in the
L1 gene as well as beta-globin specific primers, the PCR product
hybridizes to an array of immobilized oligonucleotide probes, that are
then visualized by color development. All reagents were kindly provided
by Roche Molecular Systems Inc. (Alameda, CA).
Statistical Analysis: A one-way-ANOVA (analysis of variance) was
used to calculate for statistical differences in age, age of first sexual
intercourse, number of sexual partners, steady sexual partners,
pregnancies, full term pregnancies, and abortions. The Chi-square, or
Fisher‘s exact test where appropriate, was used for comparison of other
demographic variables. Tests were run using SPSS (Statistical Package
for the Social Sciences) software, version  7.5 (SPSS Inc. 1989-1996).
RESULTS
Table 1 shows the demographic profile of the women from the four
rural localities studied. Almost forty percent of the women had fewer
than 6 years of education. The age at first sexual intercourse was in
average 17 year-old. Most of the women studied were married and have
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Table 2
Prevalence of HPV infection in four rural villages of the Bolivian Amazon
      
HPV Positive HPV HPV HPV infection
Village n subjects Types Multiple infection Prevalence (%)
San Ramón 63 2 HPV-16 HPV-16/-26/52 3.17
HPV-26
HPV-52
HPV-66
Caranavi 51 4 HPV-11 HPV-11/39 7.84
HPV-39
HPV-51
Palos Blancos 9 0 0
Rurrenabaque 12 2 HPV-6 16.6
HPV-59 HPV-59/MM8
HPV-MM8
Table 1
Demographic profile of women from four rural localities in the Bolivian Amazon
Village   
San Ramon Caranavi Palos Blancos Rurrenabaque
Variable (n=63) (n=51) (n=9) (n=12)
Ageε 36.5[16-71] 34.9[16-65] 38[23-67] 40.1[20-70] NSa
Ethnic group (%) p <0.001b
Aymara 2.9 42.4 66.7 4.3
Quechua 17.6 13 4.8 0
Mestizo 76 42.4 19 0
Other 2.9 2.2 9.5 95.7
Education (%) NSb
None 11.8 8.3 13.6 8.3
Primary 52.9 38.5 27.3 33.3
Secondary or higher 35.3 53.1 59.1 58.1
Marital status (%) p <0.05b
Married or living as married 94.1 77.2 69.6 79.2
Separated/Widowed 4.4 17.6 26.1 20.8
Single 1.5 5.9 0 6.1
Smoking status (%) p <0.05b
Smoker 9 20.7 9.1 36.4
Non-smoker 91 79.3 90.9 63.6
Age of first sexual intercourseε 17.01 [13-24] 17.31 [10-32] 17.32 [14-24] 16.71 [12-22] NSa
Number of lifetime sexual partnersε 1.57 [1-3] 1.97 [1-6] 1.79 [1-5] 1.75 [1-4] NSa
Number of steady sexual partnersε 1.22 [1-3] 1.23 [1-3] 1.26 [1-5] 1.21 [1-4] NSa
Number of pregnanciesε 5.5  [1-14] 4.69  [1-15] 6.70  [2-14] 6.21  [1-16] p <0.05a
Number of full term pregnanciesε 5.03 [1-13] 3.45 [1-10] 5.90 [2-13] 5.29 [1-16] p <0.01a
Number of abortionsε 0.68 [0-6] 1.61 [0-12] 1.41 [0-8] 1.37 [0-3] p <0.01a
Occupation (%) p <0.001b
Housewife 73.5 46.8 45.5 70.8
Merchant 16.2 24.5 13.6 0
Farmer 1.5 9.6 18.2 4.2
Professional 4.4 8.5 9.1 16.7
Others 4.4 10.6 13.6 8.3
ε
 mean [range]; NS: Non significant; a One way ANOVA; b Chi square test (or Fisher exact test, where appropriate)
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HPV types (HPV-26, -39, - 51, -52, and -59)9 were found among the
studied women. Eventhough reported as a “low-risk” type, HPV-66 has
been found present in cervical cancer11 and has been included as a high
risk in a recent review30. Two cases of dual infection, as well as one case
of triple infection were detected among the studied women. We must
pay attention to this issue as multiple infection with different HPV types
may have antagonistic or sometimes synergistic effect with respect to
carcinogenesis26. It seems to be common to find a wide variety of HPV
types in healthy women11,12,15. The classical high risk HPV-16 and HPV-
18 being uncommon in healthy women has been reported also in rural
Latin America11.
HPV DNA point prevalence reflects not only recent exposures but
also a subset of old exposures that have failed to induce an appropriate
cellular immunity and have become persistent5. These studies are very
informative in terms of evaluating the risk of developing cervical cancer
caused by the well known high risk HPVs as well as new emergent viral
genotypes.
Potential differences between rural and urban women that could help
to explain a low HPV infection prevalence were pointed out by our
group17. The relative isolation of the Amazonian cities, compared to the
more populated Andean cities, may have halted to some extent the
introduction of HPV to this region. If so we would expect very few HPV
types to be found, however we observed a quite broad type distribution
in just a few infected cases.  Even though the country is divided into
three well defined regions, during the last decades important migratory
movements from the country side to the cities have been observed, making
it difficult to clearly establish a rural-urban differentiation on an ethnic
and cultural basis25.
Most of the studied women were married,  monogamous, with less
than two life-time sexual partners, fertile housewives (Table 1). A relative
absence of risk factors for HPV transmission is a plausible explanation
for the low prevalence found. The role of other risk factors, including
lifestyle behaviors and genetic background, should be further
investigated. Specially the question whether some ethnic groups are more
susceptible to specific HPV types, or if some ethnic group has reduced
cell immunity to specific HPV types, should be studied. Since immunity
is genetically determined, ethnic differences may explain why some
women have different levels of susceptibility for specific HPV infection
or lower immune response. Variation of cofactors of HPV infection due
to ethnicity have been already reported13, and it has been observed that
Hispanic women with HPV infection have a higher risk for cervical
dysplasia compared to non Hispanic white women1.
The lack of access to medical care and cancer screening in remote
areas, may help to explain the high incidence of cervical cancer in Bolivia.
Although our study subjects were healthy women, cytology showed in a
great percentage of them reactive changes associated with inflammation.
A similar figure has been reported in some Brazilian Amazonian
women3,27. Detection and treatment of the premalignant lesions is the
basis for Papanicolaou (Pap) smear screening, which has been partly
responsible for the decline in the incidence of cervical cancer in countries
like the United States in the last two decades16. Cervical cancer should
be seen as a preventable disease6. Until the advent of effective and
accessible HPV vaccines, cervical cancer screening programs should be
strengthened specially in South American countries.
RESUMO
Prevalência da infecção pelo papilomavirus humano nas aldeias
rurais do Amazonas Boliviano
O câncer cervical constitui problema de saúde da maior importância
nos países em desenvolvimento tais como a Bolívia. O papel de certos
genótipos de papilomavirus humano (HPVs) na patologia do câncer
cervical está bem estabelecido. A prevalência da infecção pelo HPV nas
mulheres sexualmente ativas varia amplamente. Contudo, as informações
existentes acerca da infecção pelo HPV na Bolivia são muito escassas,
especialmente nas zonas rurais, nomeadamente na região amazônica do
país.
Foram estudadas 135 mulheres saudáveis, residentes em quatro
localidades do Amazonas Boliviano. Foi detectada a presença de HPV
no DNA extraído de esfregaços cervicais, utilizando o método de
hibridização em linha reversa. A prevalência da infecção por HVP,
encontrada nas localidades rurais, foi de 5,9% (variação entre 0-16,6%).
Estes valores foram inesperadamente baixos, uma vez que a Bolívia é
um país com alta incidência de câncer cervical. O fato da população do
Amazonas parecer estar menos exposta ao HPV leva-nos a pensar que
outros fatores de risco, inclusive estilos de vida e fatores genéticos,
poderiam ter alguma relevância no desenvolvimento do câncer cervical
nesta população.
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